Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Healthcare Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Multiplex PCR QAP
View:
Post by mercedesman on Dec 20, 2021 7:52am

Multiplex PCR QAP

Just announced

i would think exceeding useful in todays testing environment given pressure on labs today. 


https://stockhouse.com/news/press-releases/2021/12/20/microbix-launches-multiplex-respiratory-pcr-test-control

Comment by wizzdumb on Dec 20, 2021 9:52am
Good news and great work by the time but unlikely to move the share price at all short to mid term. Longer term this should continue to increase QAPs revenue which is very high margin. 
Comment by mercedesman on Dec 20, 2021 10:28am
I'm all about long term and sustainable revenues, so this is great news in my mind.  Won't be a ton of competition in the multiplex arena yet...so this means market advantage and likely even higher margins going forward. Sounds like, going forward, based on omicron sysmptoms it may be hard for Docs to determine if you have a basic cold, Covid, flu, etc.  So MBX's one stop ...more  
Comment by wizzdumb on Dec 20, 2021 11:05am
As an investor I am always in "show me the money" mode.  The company is in the best shape it's been in in a very long time. Need some big deals with dollars attached to make a splash and hopefully draw some more attention to the company and it's offerings. Maybe year end will do that but I highly doubt it, none of the other three quarters of record results did. We also ...more  
Microbix Biosystems Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities